Clinical evolution of neuroretinitis in Parry-Romberg syndrome

J Pediatr Ophthalmol Strabismus. 2008 Mar-Apr;45(2):125-6. doi: 10.3928/01913913-20080301-04.

Abstract

A 16-year-old girl with Parry-Romberg syndrome presented with monolateral exudative neuroretinitis and retinal telangiectasis that had been observed for 42 months. She was treated with immunosuppressive therapy with A-cyclosporine for 1 year, followed by laser treatment of telangiectasis. Her visual acuity improved from 20/200 to 20/70 in 1 year with a reduction of neuroretinal exudation. Laser treatment resulted in a further improvement of visual acuity to 20/40. Clinical findings remained unchanged during 2 years of follow-up. The association of immunosuppressive treatment and laser therapy may improve neuroretinal disease in the presence of Parry-Romberg syndrome.

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Combined Modality Therapy
  • Cyclosporine / therapeutic use
  • Facial Hemiatrophy / complications*
  • Female
  • Fluorescein Angiography
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Laser Coagulation
  • Retinitis / diagnosis
  • Retinitis / etiology*
  • Retinitis / therapy
  • Telangiectasis / diagnosis
  • Telangiectasis / etiology*
  • Telangiectasis / therapy

Substances

  • Immunosuppressive Agents
  • Cyclosporine